North American Electron Emitting High Energy Linear Accelerators (Linac) Systems Market Research Report
- Report Code: EL 1001
- Publish Date: Upcoming
The North American high energy linear accelerators (LINAC) systems market is mainly driven by rapidly changing cancer treatment technology and Growing number of cancer patients. The market was valued $1,073.8 million in 2013 and is expected to be $1,167.7 million by 2018, at a CAGR of 1.70%. Higher energy linear accelerators dominate the global radiotherapy market in different forms such as with conventional IMRT, IGRT, and stereotactic technology.
The report “High Energy Linear Accelerators (LINAC) Systems Market Forecast, 2012-2018”, analyzes the market in terms of technology such as IMRT, IGRT, stereotactic, adaptive radiation therapy, volumetric modulated arc therapy, and others.
Varian Medical system and ELEKTA AB currently hold the maximum market share for LINAC systems, and are the prominent market leaders in the radiotherapy devices market segment. Beyond these market leaders, the entire market is highly fragmented and thronged by various small and medium players.
In North America (US, Canada), the rising rates of cancer population have been driving the market growth. The market growth is significantly higher in North America because it is always inclined to the newer techniques while comparatively slow-moving markets such as Europe and Japan are maturing with both old and new technologies. North America is the most dynamic, highly competitive and the largest market for radiotherapy devices globally.
This market is still restricted to the developing countries due to the huge installation price involved. It requires highly skilled professionals for its proper application and usage. The major hindrance for these systems has been the widespread usage of other highly efficient medical robotic systems such as da-Vinci robotic system, where no radiation is involved for the treatment. Majorly, the U.S. and Europe comprise the maximum share of this market but developing countries of Asia and other regions of the world are adopting new policies to welcome such therapeutic procedures to fight against cancer.
The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in this report are Varian Medical Systems, ELEKTA AB, Accuray Incorporation, Siemens, IBA S.A, and Covidien. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies is also covered in the report.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country specific prevalence and patient pool of cancer in prostate gland, female breast and genital organs, lungs and pleura, head and neck, colorectal, spine, and brain
- Disease progression (pattern analysis)
Surgeons’/Physicians’ Perception Analysis
- Fast turn-around analysis of surgeons’ response to market events and trends
- Surgeons’ opinion about the products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of LINAC systems in various countries.
- Procedural investment in major countries for prostate cancer, brain cancer, lungs, and head and neck cancer.
Competitive Intelligence
- The company share analysis of the players of the market
- The crucial developments and strategies of companies inculcating in their portfolio.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American External Beam Radiotherapy Devices Market The North American External Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1427.1 million in 2013 and expected to be $1571.7 million by 2018, growing at a CAGR of 2.0%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
European External Beam Radiotherapy Devices Market The European External Beam Radiotherapy Devices Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $702.5 million in 2013 and expected to be $784.3 million by 2018, growing at a CAGR of 2.2%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Asian External Beam Radiotherapy Devices Market The Asian External Beam Radiotherapy Devices Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $699.2 million in 2013 and expected to be $919.6 million by 2018, growing at a CAGR of 5.6%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
